Search

everythinglearnresearchcommunity

for

Search:↓

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

PHBV nanofiber matrices help wounds heal faster when used with hair follicle cells.

Compartmentalized organization might be crucial for stem cells to effectively respond to growth or injury.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Minoxidil affects cell growth in two ways: low doses increase growth, while high doses slow it down and can be toxic.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

Regulatory T cells are essential for normal and improved wound healing in mice.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Cavity macrophages gather on organ surfaces but don't really invade or help repair the organs after injury.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

Mice with autoimmune hair loss showed signs of heart problems.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.

Finasteride and baicalin in phospholipid vesicles effectively promote hair growth and increase follicle count.

Genomic approach finds new possible treatments for hair loss.